Diagnostic performance of an automated immunoassay for salivary cortisol - 22/02/24
, Fidéline Bonnet-Serrano a, b, Marie-Clémence Leguy a, Miliça Simeonovic a, d, Catherine Sée a, Corinne Zientek a, Mickael Soussan a, b, Lucas Bouys b, c, e, Jérôme Bertherat b, c, e, Jean Guibourdenche a, b
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Highlights |
• | Saliva sampling is easy, non-invasive, and thus suitable for outpatient settings. |
• | HPLC-MS/MS is the gold standard, measuring cortisol and cortisone simultaneously. |
• | Immunoassays for cortisol may cross-react with cortisone, which is abundant in saliva. |
• | Cut-off values are lacking for salivary cortisol in adrenal dynamic tests. |
• | Automated immunoassays for salivary cortisol can be used in first line. |
Abstract |
Automated immunoanalysis (AI) is an interesting alternative for measuring salivary cortisol, as the gold standard HPLC-MS/MS method is not yet readily available. The aim of this study was to evaluate the diagnostic performance of salivary cortisol immunoassay on the iSYS immunoanalyzer in adrenal dynamic tests. Cortisol was measured on iSYS and on HPLC-MS/MS in saliva samples collected after 1mg-dexamethasone suppression test (DST) in 115 patients suspected of Cushing syndrome, and during Synacthen® stimulation test (SST) in 108 patients suspected of adrenal insufficiency. Concentrations on AI correlated well with HPLC-MS/MS (Spearman r=0.9496; P<0.0001), but with a significant positive bias. ROC analysis of salivary cortisol identified optimal cut-off values on AI and HPLC-MS/MS of respectively 3.5 and 0.77nmol/L for DST and 32.6 and 13.8nmol/L at T60 after SST. Automated immunoassays for salivary cortisol are suitable in daily practice but require determination of specific cut-off and reference values.
Il testo completo di questo articolo è disponibile in PDF.Keywords : Cortisol, Saliva, Synacthen® stimulation test, Dexamethasone suppression test, Immunoanalyzer, Mass spectrometry
Mappa
Vol 85 - N° 1
P. 20-26 - febbraio 2024 Ritorno al numero
Articolo precedente
- French guidelines from the GTE, AFCE and ENDOCAN-RENATEN (Groupe d’étude des Tumeurs Endocrines/Association Francophone de Chirurgie Endocrinienne/Reseau national de prise en charge des tumeurs endocrines) for the screening, diagnosis and management of Multiple Endocrine Neoplasia Type 1
- Pierre Goudet, Guillaume Cadiot, Anne Barlier, Eric Baudin, Françoise Borson-Chazot, Laurent Brunaud, Robert Caiazzo, Catherine Cardot-Bauters, Frédéric Castinetti, Philippe Chanson, Thomas Cuny, Eric Dansin, Sébastien Gaujoux, Sophie Giraud, Lionel Groussin, Maëlle Le Bras, Jean-Christophe Lifante, Muriel Mathonnet, Louis de Mestier, Eric Mirallié, François Pattou, Pauline Romanet, Frédéric Sebag, Christophe Tresallet, Delphine Vezzosi, Thomas Walter, Antoine Tabarin
- The experience of diagnosis announcement in rare endocrine diseases: A survey of the French FIRENDO network
- Haifa Rahabi, Maria Givony, Béatrice Demaret, Frédérique Albarel, Marie-Reine Aubron, Beate Bartès, Lucie Bernard, Hendy Abdoul, Naim Bouazza, Philippe Brun, Delphine Drui, Véronique Dujardin, Catherine Lançon, Sabine Malivoir, Irène Netchine, Bénédicte Perrotin, Virginie Picard, Rachel Reynaud, Murielle Ribeiro, Véronique Tardy Guidollet, Amélie Victor, Jérôme Bertherat, Claudine Colin, Thierry Brue
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.